For value investors, there is nothing like investing in a promising new stock immediately following its IPO. In November, a slew of companies went public, vowing fast growth and high investor returns. This includes three firms from China, one from Taiwan and one from the United Kingdom. Let’s take a quick look at these companies.
CNFinance Holdings Limited (CNF): The Chinese firm, which provides home equity loan services, offered 6 million shares during its IPO on November 7 at an offer price of $7.50. The stock closed its first trading day at $7.60 and is currently trading 8% below its offer price. Like other Chinese peers, the company has received a lukewarm response due to the cold war between Washington and Beijing.
Eton Pharmaceuticals (ETON): Trading of Eton Pharmaceuticals began on November 13, at an IPO price of $6. The company, which develops liquid formulations of various approved drugs, was earlier a unit of Imprimis Pharmaceuticals (IMMY). The company offered 3.6 million shares at the IPO to raise a total of $21.6 million. The stock is currently 9.5% higher at $6.57.
Vapotherm (VAPO): Medical technology company that specializes in the treatment of respiratory disorders, Vapotherm, went public on November 14. The offer price on the stock was $14 and it closed the opening day at $16. So far this year, the stock has jumped nearly 30%.
Weidai Ltd. (WEI): Weidai was the second Chinese financial services firm to get listed in November. The stock started raised $45 million by offering its shares at $10 on November 15. The peer-to-peer lending platform offered $4.5 million shares during the IPO. The stock witnessed a couple of short hikes and is currently trading around its offer price.
Bain Capital Specialty Finance (BCSF): The specialty finance arm of Boston-based asset management giant Bain Capital debuted on the New York Stock Exchange on November 15 by offering 7.5 million shares priced at $20.25. The IPO failed to evoke an enthusiastic response and closed the same day down at $18. The stock is so far down 11%. The company’s investment income has increased 6 times year-over-year for the first half of 2018, according to Reuters.
TuanChe Limited (TC): A leading automotive marketplace in China, TuanChe started trading on Nasdaq on November 20. The initial offer price was $7.80 and the stock closed that day 3 cents higher. Hurt by trade war concerns, TuanChe is currently trading down 8.3%.
Tiziana Life Sciences plc (TLSA): The UK-based biotechnology company went public on November 20 at an IPO price of $9.90. The company develops antibodies for the treatment of Crohn’s disease, NASH and cancer. A total of $4.4 million was raised by offering 0.4 million shares of the company. The stock has fallen 9.3% since launch.
Taiwan Liposome Company (TLC): The Taiwan-based specialty pharmaceutical firm offered 3.8 million shares priced $5.80 at its IPO on November 21. The stock is currently trading at $6.50, up 12%.
Follow our Google News edition to get the latest stock market, earnings, and financial news at your fingertips
Most Popular
Earnings Preview: Home Depot’s Q3 report likely to reflect weak consumer demand
The US housing industry has been mostly resilient to headwinds like economic uncertainties so far this year. However, housing activity cooled in recent months as high mortgage rates and inflation
Take-Two Interactive (TTWO) will report Q2 2025 earnings this week, a few points to note
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) stayed red on Monday. The stock has gained 16% over the past three months. The gaming company is set to report its second
Earnings Summary: Highlights of Loews Corporation’s (L) Q3 2024 report
Loews Corporation (NYSE: L), a diversified company with businesses in the insurance, energy, hospitality, and packaging industries, on Monday reported higher revenue and profit for the third quarter of 2024.
